Flobecq, Belgium

Stephane Carlier


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Stephane Carlier

Introduction

Stephane Carlier is a notable inventor based in Flobecq, Belgium. He has made significant strides in the field of medical imaging, particularly in the detection of microcalcifications in blood vessels. His work has the potential to enhance the understanding and treatment of cardiovascular diseases.

Latest Patents

Carlier holds a patent for a system and method for in vivo imaging of blood vessel walls to detect microcalcifications. This innovative system includes an in vivo imaging device capable of imaging a blood vessel with a resolution level of at least fifty micrometers. The device can detect microcalcifications in the fibrous cap of an atheroma. Additionally, the system features a processor that analyzes the images received from the imaging device to determine the presence of microcalcifications. In some cases, the processor can predict the risk of rupture of the fibrous cap based on the detected microcalcifications. This technology may lead to improved treatment strategies for patients with cardiovascular conditions.

Career Highlights

Throughout his career, Carlier has worked with prestigious institutions such as City University of New York and Columbia University. His experience in these academic environments has contributed to his expertise in medical imaging and innovation.

Collaborations

Carlier has collaborated with esteemed colleagues, including Sheldon Weinbaum and Yuliya Vengrenyuk. These partnerships have likely enriched his research and development efforts in the field of medical technology.

Conclusion

Stephane Carlier's contributions to medical imaging and his innovative patent demonstrate his commitment to advancing healthcare technology. His work has the potential to significantly impact the detection and treatment of cardiovascular diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…